Patents are granted for 20 years, but pharmaceutical companies can't use their patent-guaranteed monopoly powers for anywhere near this long because it takes several years to acquire approval of drugs from the Food and Drug Administration (FDA). Should the life of drug patents be extended to 20 years after FDA approval? What would be the costs and benefits of such an extension?